108 related articles for article (PubMed ID: 25472999)
1. Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2.
Geller DS; Singh MY; Zhang W; Gill J; Roth ME; Kim MY; Xie X; Singh CK; Dorfman HD; Villanueva-Siles E; Park A; Piperdi S; Gorlick R
Clin Cancer Res; 2015 Jul; 21(13):3003-12. PubMed ID: 25472999
[TBL] [Abstract][Full Text] [Related]
2. "To B(MP-2) or Not To B(MP-2)" or "Much Ado About Nothing": Are Orthobiologics in Tumor Surgery Worth the Risks?
Weiss KR
Clin Cancer Res; 2015 Jul; 21(13):2889-91. PubMed ID: 25609065
[TBL] [Abstract][Full Text] [Related]
3. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.
Gill J; Connolly P; Roth M; Chung SH; Zhang W; Piperdi S; Hoang B; Yang R; Guzik H; Morris J; Gorlick R; Geller DS
PLoS One; 2017; 12(3):e0173322. PubMed ID: 28264040
[TBL] [Abstract][Full Text] [Related]
4. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
5. To B(MP-2) or Not To B(MP-2): Cytokines and Tumor Surgery—Response.
Weiss KR
Clin Cancer Res; 2015 Sep; 21(17):4023. PubMed ID: 26330507
[No Abstract] [Full Text] [Related]
6. To B(MP-2) or Not To B(MP-2): Cytokines and Tumor Surgery—Letter.
Geller DS; Gill J; Roth M; Gorlick R
Clin Cancer Res; 2015 Sep; 21(17):4022. PubMed ID: 26330506
[No Abstract] [Full Text] [Related]
7. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
8. Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma.
Song WS; Jeon DG; Kong CB; Cho WH; Koh JS; Lee JA; Yoo JY; Jung ST; Shin DS; Lee SY
Ann Surg Oncol; 2011 Jun; 18(6):1710-6. PubMed ID: 21222166
[TBL] [Abstract][Full Text] [Related]
9. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma.
Gebhardt MC; Flugstad DI; Springfield DS; Mankin HJ
Clin Orthop Relat Res; 1991 Sep; (270):181-96. PubMed ID: 1884538
[TBL] [Abstract][Full Text] [Related]
10. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
Jeon DG; Kong CB; Cho WH; Song WS; Cho SH; Choi SW; Lee SY
J Surg Oncol; 2014 Mar; 109(3):275-9. PubMed ID: 24243222
[TBL] [Abstract][Full Text] [Related]
11. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
[TBL] [Abstract][Full Text] [Related]
12. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
13. Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma.
Granados-Garcia M; Luna-Ortiz K; Castillo-Oliva HA; Villavicencio-Valencia V; Herrera-Gómez A; Mosqueda-Taylor A; Aguilar-Ponce JL; Poitevin-Chacón A
Oral Oncol; 2006 Feb; 42(2):172-6. PubMed ID: 16246617
[TBL] [Abstract][Full Text] [Related]
14. Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?
Tamamyan G; Dominkus M; Lang S; Diakos C; Mittheisz E; Horcher E; Holter W; Zoubek A; Bielack S; Kager L
Pediatr Blood Cancer; 2015 Mar; 62(3):529-30. PubMed ID: 25611048
[TBL] [Abstract][Full Text] [Related]
15. [Current treatment of primary and metastatic osteosarcoma].
Song JG
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):881-4. PubMed ID: 23336371
[No Abstract] [Full Text] [Related]
16. [Local recurrence after surgical or surgical-chemotherapeutic treatment of osteosarcoma of the limbs. Incidence, risk factors and prognosis].
Bacci G; Donati D; Manfrini M; Forni C; Bertoni F; Gherlinzoni F; Biagini R; Campanacci M
Minerva Chir; 1998; 53(7-8):619-29. PubMed ID: 9793351
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.
Wang TI; Wu PK; Chen CF; Chen WM; Yen CC; Hung GY; Liu CL; Chen TH
Jpn J Clin Oncol; 2011 Nov; 41(11):1244-50. PubMed ID: 21994209
[TBL] [Abstract][Full Text] [Related]
19. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
Xie L; Guo W; Li Y; Ji T; Sun X
J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
[TBL] [Abstract][Full Text] [Related]
20. Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma.
Mahjoub A; Morales-Restrepo A; Fourman MS; Mandell JB; Feiqi L; Hankins ML; Watters RJ; Weiss KR
Ann Surg Oncol; 2019 Mar; 26(3):894-898. PubMed ID: 30588559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
